The Association of β2-Microglobulin and Fibroblast Growth Factor 23 with Major Adverse Cardiac Event in Acute Coronary Syndrome Patients with Chronic Kidney Disease

Eka Ginanjar, Idrus Alwi, Aida Lydia, Suzanna Immanuel, Muhammad Yamin, Taufik Indrajaya, Kuntjoro Harimurti

Research output: Contribution to journalArticlepeer-review

Abstract

BACKGROUND: chronic kidney disease (CKD) increases the severity and risk of mortality in acute coronary syndrome (ACS) patients. The role of β2-M as a filtration and inflammation marker and FGF23 as a CKD-MBD process marker might be significant in the pathophysiology in ACS with CKD patients. This study aims to determine the association of β2-M and FGF23 with major adverse cardiac event (MACE) in ACS patients with CKD. METHODS: we used cross sectional and retrospective cohort analysis for MACE. We collected ACS patients with CKD consecutively from January until October 2018 at Dr. Cipto Mangunkusumo General Hospital. Data were analyzed using logistic regression and Cox's Proportional Hazard Regression. RESULTS: a total of 117 patients were selected according to the study criteria. In bivariate analysis, β2-M, FGF23, and stage of CKD had significant association with MACE (p = 0.014, p = 0.026, p = 0.014, respectively). In multivariate analysis, β2-M - but not FGF 23- was significantly associated with MACE (adjusted HR 2.16; CI95% 1.15-4.05; p = 0.017). CONCLUSION: β2-M was significantly associated with MACE, while FGF23 was not so. This finding supports the role of inflammation in cardiovascular outcomes in ACS with CKD patient through acute on chronic effect.

Original languageEnglish
Pages (from-to)5-12
Number of pages8
JournalActa medica Indonesiana
Volume53
Issue number1
Publication statusPublished - 1 Jan 2021

Keywords

  • Acute Coronary Syndrome
  • Beta2-Microglobulin
  • Fibrioblast Growth Factor 23
  • Major Adverse Cardiac Event

Fingerprint

Dive into the research topics of 'The Association of β2-Microglobulin and Fibroblast Growth Factor 23 with Major Adverse Cardiac Event in Acute Coronary Syndrome Patients with Chronic Kidney Disease'. Together they form a unique fingerprint.

Cite this